Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
10-Feb-2016miR-515-5p controls cancer cell migration through MARK4 regulationPardo, OE; Munro, CE; Castellano, L; Hu, Y; Mauri, F, et al
12-Jan-2018A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumabEsteva, FJ; Stebbing, J; Wood-Horrall, RN; Winkle, PJ; Lee, SY, et al
10-May-2018TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionOttaviani, S; Stebbing, J; Frampton, A; Zagorac, S; Krell, J, et al
1-Jul-2017CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialStebbing, J; Baranau, Y; Baryash, V; Manikhas, A; Moiseyenko, V, et al
1-Jan-2017Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC countsShaw, JA; Guttery, DS; Hills, A; Fernandez-Garcia, D; Page, K, et al
17-Jan-2012The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancyPayne, RE; Hava, NL; Page, K; Blighe, K; Ward, B, et al